Replies to post #12176 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

If the [CAFC] error was unlikely to affect the result, why is it bullish for MNTA? If the court comes to the same conclusion, a loss is still a loss, isn't it?

MNTA won the case with respect to the ‘808 Copaxone patent in the Appellate Court (CAFC).